Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flora Tassone

Showing results (331-340 of 348) with videos related to

Pageof 35
Sort By:
Frontiers in Pediatrics|October 13, 2025
Prevalence of Fragile X syndrome in Georgian patients with autism spectrum disorder and/or intellectual disability: cross-sectional study and review of current approachesNazi Tabatadze, Otar Koniashvili, Gia Melikishvili, et al.
Disease Models & Mechanisms|September 18, 2016
Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activitySarah J Annesley, Sui T Lay, Shawn W De Piazza, et al.
Human Molecular Genetics|October 30, 2009
Fibroblast phenotype in male carriers of FMR1 premutation allelesDolores Garcia-Arocena, Jane E Yang, Judith R Brouwer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2007
Impairment of executive cognitive functioning in males with fragile X-associated tremor/ataxia syndromeJim Grigsby, Angela G Brega, Maureen A Leehey, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|December 4, 2020
Experiences with offering pro bono medical genetics services in the West Indies: Benefits to patients, physicians, and the communityAndrew K Sobering, Dong Li, Jennifer S Beighley, et al.
Cells|December 22, 2023
Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS)Ellery Santos, Courtney Clark, Hazel Maridith B Biag, et al.
SAGE Open Medicine|November 1, 2024
Negative effect of treatment with mGluR5 negative allosteric modulator AFQ056 on blood biomarkers in young individuals with Fragile X syndromeDragana Protic, Elizabeth Breeze, Guadalupe Mendoza, et al.
The Journal of Clinical Investigation|August 31, 2023
Effects of AFQ056 on language learning in fragile X syndromeElizabeth Berry-Kravis, Leonard Abbeduto, Randi Hagerman, et al.
Journal of Neurodevelopmental Disorders|September 9, 2024
Specific EEG resting state biomarkers in FXS and ASDMélodie Proteau-Lemieux, Inga Sophia Knoth, Saeideh Davoudi, et al.
Neuron|January 10, 2017
Translation of Expanded CGG Repeats into FMRpolyG Is Pathogenic and May Contribute to Fragile X Tremor Ataxia SyndromeChantal Sellier, Ronald A M Buijsen, Fang He, et al.
Pageof 35

Showing results (331-340 of 348) with videos related to

Sort By:
Pageof 35
Frontiers in Pediatrics|October 13, 2025
Prevalence of Fragile X syndrome in Georgian patients with autism spectrum disorder and/or intellectual disability: cross-sectional study and review of current approachesNazi Tabatadze, Otar Koniashvili, Gia Melikishvili, et al.
Disease Models & Mechanisms|September 18, 2016
Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activitySarah J Annesley, Sui T Lay, Shawn W De Piazza, et al.
Human Molecular Genetics|October 30, 2009
Fibroblast phenotype in male carriers of FMR1 premutation allelesDolores Garcia-Arocena, Jane E Yang, Judith R Brouwer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2007
Impairment of executive cognitive functioning in males with fragile X-associated tremor/ataxia syndromeJim Grigsby, Angela G Brega, Maureen A Leehey, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|December 4, 2020
Experiences with offering pro bono medical genetics services in the West Indies: Benefits to patients, physicians, and the communityAndrew K Sobering, Dong Li, Jennifer S Beighley, et al.
Cells|December 22, 2023
Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS)Ellery Santos, Courtney Clark, Hazel Maridith B Biag, et al.
SAGE Open Medicine|November 1, 2024
Negative effect of treatment with mGluR5 negative allosteric modulator AFQ056 on blood biomarkers in young individuals with Fragile X syndromeDragana Protic, Elizabeth Breeze, Guadalupe Mendoza, et al.
The Journal of Clinical Investigation|August 31, 2023
Effects of AFQ056 on language learning in fragile X syndromeElizabeth Berry-Kravis, Leonard Abbeduto, Randi Hagerman, et al.
Journal of Neurodevelopmental Disorders|September 9, 2024
Specific EEG resting state biomarkers in FXS and ASDMélodie Proteau-Lemieux, Inga Sophia Knoth, Saeideh Davoudi, et al.
Neuron|January 10, 2017
Translation of Expanded CGG Repeats into FMRpolyG Is Pathogenic and May Contribute to Fragile X Tremor Ataxia SyndromeChantal Sellier, Ronald A M Buijsen, Fang He, et al.
Pageof 35